Polymorphisms of matrix metalloproteinases in myocardial infarction: A meta-analysis

Heart

Volumn 97, Issue 19, 2011, Pages 1542-1546

  Wang, Junhong ^a   Di, Xu ^a   Xin, Wu ^a   Zhou, Chuanwei ^a   Hui, Wang ^a,b   Yan, Guo ^a   Cao, Kejiang ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b Department of Cardiology   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOSINE; GELATINASE B; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE 5A; MATRIX METALLOPROTEINASE 6A; STROMELYSIN; THYMINE; UNCLASSIFIED DRUG;

ALLELE; AMINO ACID SUBSTITUTION; ASIAN; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR RISK; CASE CONTROL STUDY; CAUCASIAN; DATA ANALYSIS; EAST ASIAN; ETHNIC DIFFERENCE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HEART INFARCTION; HUMAN; MEDLINE; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; SYSTEMATIC REVIEW;

CONTINENTAL POPULATION GROUPS; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LOGISTIC MODELS; MATRIX METALLOPROTEINASE 3; MATRIX METALLOPROTEINASE 9; MATRIX METALLOPROTEINASES, SECRETED; MYOCARDIAL INFARCTION; MYOCARDIUM; ODDS RATIO; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK ASSESSMENT; RISK FACTORS;

EID: 80052658067     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/heartjnl-2011-300342     Document Type: Review

References (30)

1. Dabek J, Kulach A, Gasior Z. The role of matrix metalloproteinases in acute coronary syndromes. Eur J Intern Med 2007;18:463-6. (Pubitemid 47379537)
2. Koh YS, Chang K, Kim PJ, et al. A close relationship between functional polymorphism in the promoter region of matrix metalloproteinase-9 and acute myocardial infarction. Int J Cardiol 2008;127:430-2. (Pubitemid 351885094)
3. Pearce E, Tregouet DA, Samnegard A, et al. Haplotype effect of the matrix metalloproteinase-1 gene on risk of myocardial infarction. Circ Res 2005;97:1070-6. (Pubitemid 41668921)
4. Ye S. Influence of matrix metalloproteinase genotype on cardiovascular disease susceptibility and outcome. Circ Res 2006;69:636-45. (Pubitemid 43139726)
5. Koch W, De Waha A, Hoppmann P, et al. Haplotypes and 5A/6A polymorphism of the matrix metalloproteinase-3 gene in coronary disease: case-control study and a meta-analysis. Atherosclerosis 2010;208:171-6.
6. Shioji K, Kokubo Y, Goto Y, et al. An association analysis between genetic polymorphisms of matrix metalloproteinase-3 and methylenetetrahydrofolate reductase and myocardial infarction in Japanese. J Thromb Haemost 2004;2:527-8. (Pubitemid 40185669)
7. Horne BD, Camp NJ, Carlquist JF, et al. Multiple-polymorphism associations of 7 matrix metalloproteinase and tissue inhibitor metalloproteinase genes with myocardial infarction and angiographic coronary artery disease. Am Heart J 2007;154:751-8. (Pubitemid 47429598)
8. Roman-Garcia P, Coto E, Reguero JR, et al. Matrix metalloproteinase 1 promoter polymorphisms and risk of myocardial infarction: a case-control study in a Spanish population. Coron Artery Dis 2009;20:383-6.
9. Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000;283:2008-12. (Pubitemid 30214957)
10. Ghaderian SM, Akbarzadeh Najar R, Tabatabaei Panah AS. Genetic polymorphisms and plasma levels of matrix metalloproteinases and their relationships with developing acute myocardial infarction. Coron Artery Dis 2010;21:330-5.
11. Nojiri T, Morita H, Imai Y, et al. Genetic variations of matrix metalloproteinase-1 and -3 promoter regions and their associations with susceptibility to myocardial infarction in Japanese. Int J Cardiol 2003;92:181-6. (Pubitemid 37509980)
12. Alp E, Menevse S, Tulmac M, et al. The role of matrix metalloproteinase-2 promoter polymorphisms in coronary artery disease and myocardial infarction. Genet Test Mol Biomarkers 2010;15:193-202.
13. Delgado-Enciso I, Gonzalez-Hernandez NA, Baltazar-Rodriguez LM, et al. Association of matrix metalloproteinase-2 gene promoter polymorphism with myocardial infarction susceptibility in a Mexican population. J Genet 2009;88:249-52.
14. Zhou X, Huang J, Chen J, et al. Haplotype analysis of the matrix metalloproteinase 3 gene and myocardial infarction in a Chinese Han population. The Beijing atherosclerosis study. Thromb Haemost 2004;92:867-73. (Pubitemid 39402920)
15. Tobin MD, Braund PS, Burton PR, et al. Genotypes and haplotypes predisposing to myocardial infarction: a multilocus case-control study. Eur Heart J 2004;25:459-67. (Pubitemid 38524270)
16. Yamada Y, Izawa H, Ichihara S, et al. Prediction of the risk of myocardial infarction from polymorphisms in candidate genes. N Engl J Med 2002;347:1916-23. (Pubitemid 35429921)
17. Schwarz A, Haberbosch W, Tillmanns H, et al. The stromelysin-1 5A/6A promoter polymorphism is a disease marker for the extent of coronary heart disease. Dis Markers 2002;18:121-8. (Pubitemid 35417399)
18. Terashima M, Akita H, Kanazawa K, et al. Stromelysin promoter 5A/6A polymorphism is associated with acute myocardial infarction. Circulation 1999;99:2717-19. (Pubitemid 29250015)
19. Zhi H, Wang H, Ren L, et al. Functional polymorphisms of matrix metallopeptidase-9 and risk of coronary artery disease in a Chinese population. Mol Biol Rep 2010;37:13-20.
20. Nuzzo D, Vasto S, Balistreri CR, et al. Role of proinflammatory alleles in longevity and atherosclerosis: results of studies performed on -1562C/T MMP-9 in centenarians and myocardial infarction patients from Sicily. Ann N Y Acad Sci 2006;1089:496-501. (Pubitemid 47092101)
21. Haberbosch W, Gardemann A. Gelatinase B C(-1562)T polymorphism in relation to ischaemic heart disease. Scand J Clin Lab Invest 2005;65:513-22. (Pubitemid 41499253)
22. Zhang B, Ye S, Herrmann SM, et al. Functional polymorphism in the regulatory region of gelatinase B gene in relation to severity of coronary atherosclerosis. Circulation 1999;99:1788-94. (Pubitemid 29181405)
23. Preuss M, Konig IR, Thompson JR, et al. Design of the Coronary ARtery DIsease Genome-Wide Replication And Meta-Analysis (CARDIoGRAM) study: a genome-wide association meta-analysis involving more than 22 000 cases and 60 000 controls. Circ Cardiovasc Genet 2010;3:475-83.
24. Wang AZ, Li L, Zhang B, et al. Association of SNP rs17465637 on chromosome 1q41 and rs599839 on 1p13.3 with myocardial infarction in an American Caucasian population. Ann Hum Genet 2011;75:475-82.
25. Beyzade S, Zhang S, Wong YK, et al. Influences of matrix metalloproteinase-3 gene variation on extent of coronary atherosclerosis and risk of myocardial infarction. J Am Coll Cardiol 2003;41:2130-7. (Pubitemid 36724257)
26. Samnegard A, Silveira A, Lundman P, et al. Serum matrix metalloproteinase-3 concentration is influenced by MMP-3 -1612 5A/6A promoter genotype and associated with myocardial infarction. J Intern Med 2005;258:411-19. (Pubitemid 41546556)
27. Liu PY, Chen JH, Li YH, et al. Synergistic effect of stromelysin-1 (matrix metalloproteinase-3) promoter 5A/6A polymorphism with smoking on the onset of young acute myocardial infarction. Thromb Haemost 2003;9:132-9.
28. Rockman MV, Hahn MW, Soranzo N, et al. Positive selection on MMP3 regulation has shaped heart disease risk. Curr Biol 2004;14:1531-9. (Pubitemid 39290050)
29. Galis ZS, Khatri JJ. Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly. Circ Res 2002;90:251-62. (Pubitemid 34633925)
30. Medley TL, Cole TJ, Dart AM, et al. Matrix metalloproteinase-9 genotype influences large artery stiffness through effects on aortic gene and protein expression. Arterioscler Thromb Vasc Biol 2004;24:1479-84. (Pubitemid 39050444)